The Current Management of Hepatorenal Syndrome–Acute Kidney Injury in the United States and the Potential of Terlipressin

Acute kidney injury (AKI) in the setting of cirrhosis (hepatorenal syndrome [HRS]–AKI) is a severe and often fatal complication of end‐stage liver disease. The goals of treatment are to reverse renal failure and prolong survival in patients who are critically ill. However, interventions have limited...

Descripción completa

Detalles Bibliográficos
Autores principales: Flamm, Steven L., Brown, Kimberly, Wadei, Hani M., Brown, Robert S., Kugelmas, Marcelo, Samaniego‐Picota, Milagros, Burra, Patrizia, Poordad, Fred, Saab, Sammy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review Articles and Practice‐Based Recommendations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457138/
https://www.ncbi.nlm.nih.gov/pubmed/33848394
http://dx.doi.org/10.1002/lt.26072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457138/
https://www.ncbi.nlm.nih.gov/pubmed/33848394
http://dx.doi.org/10.1002/lt.26072

Ejemplares similares